Structural basis of Jak3-mediated interleukin-2 family signal transduction
Project Number5R01AI075133-02
Contact PI/Project LeaderBOGGON, TITUS JONATHON
Awardee OrganizationYALE UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): Proper function of cytokine signaling pathways is critical for immunoregulation, hematopoiesis, and cytokine- directed inflammation and growth. Most signals from type I and type II cytokines are mediated by the Janus kinase (Jak) family of non-receptor tyrosine kinases. Our plan is to discover the molecular basis for cytoplasmic signal transduction from the interleukin-2 family cytokines through Jak3. We will use structural biology to provide the first description of Jak interactions with cytokine receptor cytoplasmic tails, to investigate Jak kinase domain specificity, regulation and inhibition, and to describe the role of the PERM domain in kinase activation. Specifically, we will focus our work in three distinct areas. In Aim 1 we will determine crystal structures of the kinase domain of Jak3. Modulation of the immune response by suppression of Jak3 kinase activity has clinical precedence. We will determine the mode of binding for Jak3 tyrosine kinase inhibitors and aid the discovery of further inhibitors that may be useful as immunomodulatory and anti-proliferative therapies. We will also discover the mode of Jak3 binding to a Jak3-preferred substrate and discover the inactive conformation of the kinase. In Aim 2, we will determine the structural basis for the almost exclusive Jak3 association with the interleukin-2 receptor gamma subunit. For this we will solve crystal structures that describe the interaction of the Jak3 PERM domain with peptides from the interleukin-2 receptor gamma subunit and investigate their binding affinities. Finally, following our structural studies on the kinase and PERM domains of Jak3, in Aim 3 we will determine the structural basis for Jak3 kinase domain association with the Jak3 FERM domain. We will also test the role of this interface as a suggested Jak3 active state stabilizing mechanism. These studies will directly impact healthcare stimulating the development of improved immunomodulatory and anti-proliferative therapies and by enhancing molecular-level understanding of cytokine signaling pathways.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
01-June-2007
Project End Date
31-May-2012
Budget Start Date
01-June-2008
Budget End Date
31-May-2009
Project Funding Information for 2008
Total Funding
$405,786
Direct Costs
$245,250
Indirect Costs
$160,536
Year
Funding IC
FY Total Cost by IC
2008
National Institute of Allergy and Infectious Diseases
$405,786
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI075133-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI075133-02
Patents
No Patents information available for 5R01AI075133-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI075133-02
Clinical Studies
No Clinical Studies information available for 5R01AI075133-02
News and More
Related News Releases
No news release information available for 5R01AI075133-02
History
No Historical information available for 5R01AI075133-02
Similar Projects
No Similar Projects information available for 5R01AI075133-02